Pathology - Research and Practice, Год журнала: 2024, Номер 260, С. 155412 - 155412
Опубликована: Июнь 14, 2024
Язык: Английский
Pathology - Research and Practice, Год журнала: 2024, Номер 260, С. 155412 - 155412
Опубликована: Июнь 14, 2024
Язык: Английский
Journal of Molecular Structure, Год журнала: 2025, Номер unknown, С. 142364 - 142364
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Comparative Immunology Reports, Год журнала: 2025, Номер unknown, С. 200211 - 200211
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Pathology - Research and Practice, Год журнала: 2024, Номер 261, С. 155490 - 155490
Опубликована: Июль 26, 2024
Язык: Английский
Процитировано
3Frontiers in Pharmacology, Год журнала: 2024, Номер 15
Опубликована: Июль 25, 2024
Long noncoding RNAs (lncRNAs) constitute a distinctive subset of RNA molecules with limited protein-coding potential, which exert crucial impacts on various biological activities. In the context cancer, dysregulated lncRNAs function as essential regulators that affect tumor initiation and malignant progression. These serve competitive endogenous (ceRNAs) through sponging microRNAs regulating expression targeted genes. Moreover, they also directly bind to RNA-binding proteins, can be integrated into complex mechanistic network. E2F1, an extensively studied transcription factor, mediates multiple behaviors by cell cycle progression, metastasis, therapeutic response. Emerging evidence suggests play pivotal role in E2F1 pathway. This review aims elucidate intricate gene regulatory programs between cancer We elaborate distinct networks involved emphasizing potential lncRNAs/E2F1 axes promising targets for therapy. Additionally, we provide novel perspectives current evidence, limitations, future directions targeting human cancers. Fully deciphering network lncRNA/E2F1-mediated mechanisms could facilitate translation findings clinical course, such efforts ultimately significantly improve prognosis patients.
Язык: Английский
Процитировано
2Epigenomics, Год журнала: 2024, Номер 16(23-24), С. 1453 - 1464
Опубликована: Ноя. 27, 2024
Neurofibromatosis (NF) is identified as genetic disorder characterized by multiple tumors on nerve tissues. NF1 the most prevalent form, neurofibromas and skin changes. neurofibromatosis disorder, distinct from rarer NF2 schwannomatosis (SWN) conditions. NF2, including NF2-related SWN (NF2-SWN), predominantly involves schwannoma formation differs
Язык: Английский
Процитировано
1Regenerative Therapy, Год журнала: 2024, Номер 28, С. 214 - 226
Опубликована: Дек. 25, 2024
Язык: Английский
Процитировано
0Pathology - Research and Practice, Год журнала: 2024, Номер 260, С. 155412 - 155412
Опубликована: Июнь 14, 2024
Язык: Английский
Процитировано
0